BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31842241)

  • 41. [The development of early cancer detection in Germany].
    Hense HW
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec; 61(12):1484-1490. PubMed ID: 30310927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Standardized documentation in emergency departments with the core dataset of the DIVI].
    Walcher F; Kulla M; Klinger S; Röhrig R; Wyen H; Bernhard M; Gräff I; Nienaber U; Petersen P; Himmelreich H; Schweigkofler U; Marzi I; Lefering R
    Unfallchirurg; 2012 May; 115(5):457-63. PubMed ID: 22527957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation of external quality assurance in accordance with sect. 137 SGB V at the Carl Gustav Carus university hospital in Dresden].
    Petzold T; Steinwitz A; Schmitt J; Eberlein-Gonska M
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(8):541-7. PubMed ID: 24290668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality Indicators for Global Benchmarking of Localized Prostate Cancer Management.
    Sampurno F; Zheng J; Di Stefano L; Millar JL; Foster C; Fuedea F; Higano C; Hulan H; Mark S; Moore C; Richardson A; Sullivan F; Wenger NS; Wittmann D; Evans S
    J Urol; 2018 Aug; 200(2):319-326. PubMed ID: 29477721
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical and epidemiological cancer registration in Germany].
    Hölzel D; Schubert-Fritschle G; Schmidt M; Eckel R; Engel J
    Pathologe; 2016 Jul; 37(4):371-87. PubMed ID: 27384334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of quality of care and guideline-compliant treatment in psoriasis. Development of a new system of quality indicators.
    Radtke MA; Reich K; Blome C; Kopp I; Rustenbach SJ; Schäfer I; Augustin M
    Dermatology; 2009; 219(1):54-8. PubMed ID: 19420901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population-based Cancer Screening: Measurement of Coordination and Continuity of Care.
    Benito L; Espinosa J; Binefa G; Vidal C; Lluch MT; Puig M; Fernandez M; Padrol I; García M
    Cancer Nurs; 2018; 41(4):E1-E11. PubMed ID: 28622194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Indicators based on registers and administrative data for breast cancer: routine evaluation of oncologic care pathway can be implemented.
    Andreano A; Anghinoni E; Autelitano M; Bellini A; Bersani M; Bizzoco S; Cavalieri d'Oro L; Decarli A; Lucchi S; Mannino S; Panciroli E; Rebora P; Rognoni M; Sampietro G; Villa M; Zocchetti C; Zucchi A; Valsecchi MG; Russo AG;
    J Eval Clin Pract; 2016 Feb; 22(1):62-70. PubMed ID: 26290172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Regional implementation of guidelines as a lesson for cancer centers].
    Sauer H
    Z Arztl Fortbild Qualitatssich; 1999 Jan; 93(1):23-7. PubMed ID: 10198974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a quality indicator set to measure and improve quality of ICU care for patients with traumatic brain injury.
    Huijben JA; Wiegers EJA; de Keizer NF; Maas AIR; Menon D; Ercole A; Citerio G; Lecky F; Wilson L; Cnossen MC; Polinder S; Steyerberg EW; van der Jagt M; Lingsma HF;
    Crit Care; 2019 Mar; 23(1):95. PubMed ID: 30902117
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Structured documentation for quality management in patients with diabetes mellitus].
    Brenner G; Altenhofen L
    Z Arztl Fortbild Qualitatssich; 1998 Mar; 92(2):123-30. PubMed ID: 9577900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Indicator analysis of prostate cancer centers certified by the German Cancer Society 2015].
    Fichtner J; Kowalski C; Wesselmann S; Albers P
    Urologe A; 2015 Nov; 54(11):1530, 1532-6. PubMed ID: 26573670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The paradigm shift in cervical cancer screening in Germany.
    Hillemanns P
    Arch Gynecol Obstet; 2016 Jan; 293(1):3-4. PubMed ID: 26514679
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics of national registries for occupational diseases: international development and validation of an audit tool (ODIT).
    Spreeuwers D; de Boer AG; Verbeek JH; van Dijk FJ
    BMC Health Serv Res; 2009 Oct; 9():194. PubMed ID: 19852775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Benchmarking: how to measure outcome quality at the comprehensive oncology centre in Stuttgart].
    Meisner C; Brinkmann F; Henke D; Junack C; Faisst S; Heidemann E
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(5):365-70. PubMed ID: 21767795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluating the scientific basis of quality indicators in colorectal cancer care: A systematic review.
    Keikes L; Koopman M; Tanis PJ; Lemmens VEPP; Punt CJA; van Oijen MGH
    Eur J Cancer; 2017 Nov; 86():166-177. PubMed ID: 28988017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient information, communication and competence empowerment in oncology (PIKKO) - evaluation of a supportive care intervention for overall oncological patients. Study protocol of a non-randomized controlled trial.
    Schneider N; Bäcker A; Brenk-Franz K; Keinki C; Hübner J; Brandt F; von der Winkel G; Hager L; Strauss B; Altmann U
    BMC Med Res Methodol; 2020 May; 20(1):120. PubMed ID: 32414331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Assessment of quality indicators with routine data: Presentation of a feasibility test in ten specialist clinics for psychiatry and psychotherapy].
    Großimlinghaus I; Falkai P; Gaebel W; Hasan A; Jänner M; Janssen B; Reich-Erkelenz D; Grüber L; Böttcher V; Wobrock T; Zielasek J;
    Nervenarzt; 2015 Nov; 86(11):1393-9. PubMed ID: 26122639
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality indicators for the evaluation of patients with lung cancer.
    Mazzone PJ; Vachani A; Chang A; Detterbeck F; Cooke D; Howington J; Dodi A; Arenberg D
    Chest; 2014 Sep; 146(3):659-669. PubMed ID: 24700172
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of Indicators to Assess Quality of Care for Prostate Cancer.
    Nag N; Millar J; Davis ID; Costello S; Duthie JB; Mark S; Delprado W; Smith D; Pryor D; Galvin D; Sullivan F; Murphy ÁC; Roder D; Elsaleh H; Currow D; White C; Skala M; Moretti KL; Walker T; De Ieso P; Brooks A; Heathcote P; Frydenberg M; Thavaseelan J; Evans SM
    Eur Urol Focus; 2018 Jan; 4(1):57-63. PubMed ID: 28753751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.